<DOC>
	<DOCNO>NCT02440178</DOCNO>
	<brief_summary>The purpose study determine whether prophylaxis micafungin effective induction chemotherapy newly diagnose acute leukemia patient .</brief_summary>
	<brief_title>Micafungin Prophylaxis During 1st Induction Chemotherapy De Novo Acute Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>A. patient belong either A1 A2 A1 . patient newly diagnose acute myeloid leukemia approve get induction chemotherapy ( cytarabine plus idarubicin ) ( modify Fludarabine + cytarabine + idarubicin ) A2 . patient newly diagnose acute lymphoid leukemia approve get induction chemotherapy VPDL ( vincristine + prednisolone + daunorubicin + Lasparaginase ) , CVPDL ( cyclophosphamide + vincristine + prednisolone + daunorubicin + Lasparaginase ) , ( R ) hyperCVAD ( ( Rituximab ) + cyclophosphamide + vincristine + Adriamycin + dexamethasone ) B . Eastern Cooperative Oncology Group performance status score equal 2 C. patient voluntarily sign agreement A. evidence proven/probable/possible fungal infection within 30 day induction chemotherapy B. hypersensitivity echinocandin C. patient malignancy within 5 year D. previous treatment history chemotherapy , radiation therapy , immunosuppressive therapy . E. pregnant breastfeed woman F. immunodeficient patient include AIDS G. patient uncontrolled seizure psychiatric disorder H. clinically significant heart disorder ( myocardial infarction within 3 month leave ventricular ejection fraction &lt; 40 % ) I. interstitial lung disease J. previous organ transplantation history K. galactose intolerance L. patient participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>leukemia</keyword>
	<keyword>induction</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>antifungal</keyword>
	<keyword>micafungin</keyword>
	<keyword>phase II</keyword>
</DOC>